David Sides - Streamline Health CEO and President and Director
| STRM Stock | USD 0.34 0.01 3.03% |
CEO
Mr. David William Sides is Director of the Company. He has served as President, Chief Executive Officer and a member of the Companys board of directors since January 2015, and will continue to serve in such capacity. From September 2014 until he was appointed to his current positions, Mr. Sides served as Executive Vice President and Chief Operating Officer of the Company. Mr. Sides served as Chief Executive Officer of iMDsoft from July 2012 to March 2014. While with iMDsoft, a global leader of highend clinical information systems, Mr. Sides led the companys transformation following the acquisition of the company by a private equity firm. From 1995 to 2012, Mr. Sides held a number of successive positions at Cerner Corporationrationration, a global supplier of health care information technology solutions, services, devices and hardware, culminating in serving as Senior Vice President of Worldwide Consulting. In that position, he led professional services in 24 countries worldwide. From March 2014 to September 2014, Mr. Sides was an independent consultant. Mr. Sides currently serves on the Board of Directors of EMIS Group PLC, a major provider of healthcare software, information technology and related services in the United Kingdom. Mr. Sides has a B.A. in biophysics from the University of California, Berkeley as well as masters of both health administration and business administration from the University of Missouri, Columbia. Mr. Sides is a Fellow of the American College of Healthcare Executives. since 2019.
| Age | 46 |
| Tenure | 5 years |
| Address | 2400 Old Milton Pkwy, Alpharetta, GA, United States, 30009 |
| Phone | 888 997 8732 |
| Web | https://www.streamlinehealth.net |
David Sides Latest Insider Activity
Tracking and analyzing the buying and selling activities of David Sides against Streamline Health stock is an integral part of due diligence when investing in Streamline Health. David Sides insider activity provides valuable insight into whether Streamline Health is net buyers or sellers over its current business cycle. Note, Streamline Health insiders must abide by specific rules, including filing SEC forms every time they buy or sell Streamline Health'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
David Sides over three months ago Payment of 18931 shares by David Sides of Nextgen Healthcare subject to Rule 16b-3 | ||
David Sides over six months ago Exercise or conversion by David Sides of 24333 shares of Nextgen Healthcare subject to Rule 16b-3 |
Streamline Health Management Efficiency
The company has return on total asset (ROA) of (0.1144) % which means that it has lost $0.1144 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7237) %, meaning that it created substantial loss on money invested by shareholders. Streamline Health's management efficiency ratios could be used to measure how well Streamline Health manages its routine affairs as well as how well it operates its assets and liabilities. As of the 25th of April 2024, Return On Tangible Assets is likely to grow to -0.7. In addition to that, Return On Capital Employed is likely to grow to -0.26. At this time, Streamline Health's Total Assets are very stable compared to the past year. As of the 25th of April 2024, Non Current Assets Total is likely to grow to about 55 M, while Total Current Assets are likely to drop about 12.8 M.Similar Executives
| Found 5 records | CEO Age | ||
| Lennart Flem | National Research Corp | N/A | |
| Oivind Horpestad | National Research Corp | N/A | |
| Thomas Leonard | Agiliti | 56 | |
| Jon Kessler | HealthEquity | 56 | |
| Michael Hays | National Research Corp | 69 | |
Management Performance
| Return On Equity | -0.72 | ||||
| Return On Asset | -0.11 |
Streamline Health Leadership Team
Elected by the shareholders, the Streamline Health's board of directors comprises two types of representatives: Streamline Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Streamline. The board's role is to monitor Streamline Health's management team and ensure that shareholders' interests are well served. Streamline Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Streamline Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ben Stilwill, President | ||
| Donald Vick, Director Analytics | ||
| Jawad Shaikh, Chief Officer | ||
| Wyche Green, Director | ||
| David Sides, CEO and President and Director | ||
| Jacob Goldberger, Director FPA | ||
| Wendy Lucio, Chief Officer | ||
| Wendy Lovvorn, Chief Officer | ||
| Lois Rickard, Chief People Officer and Sr. VP | ||
| Luciana Mullen, Principal Accounting Officer | ||
| Amy Sebero, Chief Officer | ||
| Shaun Priest, Senior Vice President and Chief Growth Officer | ||
| Bryant Reeves, Interim Staff | ||
| Wyche III, Executive Chairman | ||
| Jack Kennedy, Chief Legal Counsel and Sr. VP of Admin. | ||
| Lance Seach, Senior Development | ||
| Kenan Lucas, Director | ||
| Nicholas Meeks, CFO, Senior Vice President | ||
| Michael Valentine, Independent Director | ||
| Allen Moseley, Independent Director | ||
| Randolph Salisbury, Chief Marketing Officer and Sr. VP | ||
| Jonathan Phillips, Independent Chairman of the Board | ||
| Benjamin Stilwill, Chief Officer | ||
| William Garvis, COO, Senior Vice President | ||
| Michael Kaplan, Independent Director | ||
| Judith Starkey, Director | ||
| Thomas Gibson, CFO, Senior Vice President | ||
| MB CCS, VP eValuator |
Streamline Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Streamline Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.72 | ||||
| Return On Asset | -0.11 | ||||
| Profit Margin | (0.81) % | ||||
| Operating Margin | (0.71) % | ||||
| Current Valuation | (1.85 M) | ||||
| Shares Outstanding | 59.09 M | ||||
| Shares Owned By Insiders | 28.21 % | ||||
| Shares Owned By Institutions | 31.84 % | ||||
| Number Of Shares Shorted | 58.15 K | ||||
| Price To Earning | 321.67 X |
Currently Active Assets on Macroaxis
When determining whether Streamline Health is a strong investment it is important to analyze Streamline Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Streamline Health's future performance. For an informed investment choice regarding Streamline Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Streamline Health Solutions. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Complementary Tools for Streamline Stock analysis
When running Streamline Health's price analysis, check to measure Streamline Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Streamline Health is operating at the current time. Most of Streamline Health's value examination focuses on studying past and present price action to predict the probability of Streamline Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Streamline Health's price. Additionally, you may evaluate how the addition of Streamline Health to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
Is Streamline Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Streamline Health. If investors know Streamline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Streamline Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 12.131 | Earnings Share (0.35) | Revenue Per Share 0.428 | Quarterly Revenue Growth (0.01) | Return On Assets (0.11) |
The market value of Streamline Health is measured differently than its book value, which is the value of Streamline that is recorded on the company's balance sheet. Investors also form their own opinion of Streamline Health's value that differs from its market value or its book value, called intrinsic value, which is Streamline Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Streamline Health's market value can be influenced by many factors that don't directly affect Streamline Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Streamline Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Streamline Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Streamline Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.